Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
Raymond L. Comenzo(Tufts Medical Center), Giampaolo Merlini(University of Pavia), Vaishali Sanchorawala(Boston Medical Center), Morie A. Gertz(Medical University of South Carolina), Robert A. Kyle(Mayo Clinic), David C. Seldin(Boston University), Donna Reece(Princess Margaret Cancer Centre), Ashutosh Wechalekar(University College Hospital), Rodney H. Falk(Brigham and Women's Hospital), Jeff Zonder(Wayne State University), Giovanni Palladini(University of Pavia), Karen Wells(University of Tennessee at Knoxville), Alina Solomon(University of Eastern Finland), Howard Streicher(National Cancer Institute), Angela Dispenzieri(Mayo Clinic), M Skinner, Heather Landau(Memorial Sloan Kettering Cancer Center)
Cited by 383
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k